Gene · 4145
Papers2,664
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
881 to 900 of 2,664
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| CD5 levels define functionally heterogeneous populations of naïve human CD4+ T cells. | Eur J Immunol | 2021 | 33682083 | PubTator, text mining | PubMed |
| Evolutionary relationships, biogeography and morphological characters of Glinus (Molluginaceae), with special emphasis on the genus composition in Sub-Saharan Africa. | PhytoKeys | 2021 | 33679173 | PubTator, text mining | PubMed |
| Clinical Candidates Targeting the ATR-CHK1-WEE1 Axis in Cancer. | Cancers (Basel) | 2021 | 33672884 | PubTator, text mining | PubMed |
| Facilitating Drug Discovery in Breast Cancer by Virtually Screening Patients Using In Vitro Drug Response Modeling. | Cancers (Basel) | 2021 | 33672646 | PubTator, text mining | PubMed |
| HMGA2 as a Critical Regulator in Cancer Development. | Genes (Basel) | 2021 | 33668453 | PubTator, text mining | PubMed |
| PPAR-gamma induced AKT3 expression increases levels of mitochondrial biogenesis driving prostate cancer. | Oncogene | 2021 | 33654198 | PubTator, text mining | PubMed |
| The Association Between the Gut Microbiota and Parkinson's Disease, a Meta-Analysis. | Front Aging Neurosci | 2021 | 33643026 | PubTator, text mining | PubMed |
| Identification of Vicia Species Native to South Korea Using Molecular and Morphological Characteristics. | Front Plant Sci | 2021 | 33633762 | PubTator, text mining | PubMed |
| Why Variation in Flower Color May Help Reproductive Success in the Endangered Australian Orchid Caladenia fulva. | Front Plant Sci | 2021 | 33633758 | PubTator, text mining | PubMed |
| Correlation of immune infiltration with clinical outcomes in breast cancer patients: The 25-gene prognostic signatures model. | Cancer Med | 2021 | 33626234 | PubTator, text mining | PubMed |
| Effect of a genetically engineered interferon-alpha versus traditional interferon-alpha in the treatment of moderate-to-severe COVID-19: a randomised clinical trial. | Ann Med | 2021 | 33620016 | PubTator, text mining | PubMed |
| Quantification of Actaea racemosa L. (black cohosh) from some of its potential adulterants using qPCR and dPCR methods. | Sci Rep | 2021 | 33619286 | PubTator, text mining | PubMed |
| DNA Barcoding of St. John's wort (Hypericum spp.) Growing Wild in North-Eastern Greece. | Planta Med | 2021 | 33618378 | PubTator, text mining | PubMed |
| Taxonomic revision of the threatened African genus Pseudohydrosme Engl. (Araceae), with P. ebo, a new, critically endangered species from Ebo, Cameroon. | PeerJ | 2021 | 33614269 | PubTator, text mining | PubMed |
| Relative genetic diversity of the rare and endangered Agave shawii ssp. shawii and associated soil microbes within a southern California ecological preserve. | Ecol Evol | 2021 | 33614006 | PubTator, text mining | PubMed |
| Plastome of Saraca asoca (Detarioideae, Fabaceae): Annotation, comparison among subfamily and molecular typing. | Saudi J Biol Sci | 2021 | 33613076 | PubTator, text mining | PubMed |
| A second species of Pseuduvaria in China: the identity of the enigmatic species Meiogyne kwangtungensis. | PhytoKeys | 2021 | 33597827 | PubTator, text mining | PubMed |
| Building Organs Using Tissue-Specific Microenvironments: Perspectives from a Bioprosthetic Ovary. | Trends Biotechnol | 2021 | 33593603 | PubTator, text mining | PubMed |
| Targeting cancer stem cells for reversing therapy resistance: mechanism, signaling, and prospective agents. | Signal Transduct Target Ther | 2021 | 33589595 | PubTator, text mining | PubMed |
| No Tumorigenicity of Allogeneic Induced Pluripotent Stem Cells in Major Histocompatibility Complex-matched Cynomolgus Macaques. | Cell Transplant | 2021 | 33588604 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4145/papers?page=45